Xiaoping Su
Zhejiang Chinese Medical University(CN)The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Sun Yat-sen University(CN)Guangxi Medical University(CN)Nanjing Forestry University(CN)Wenzhou Medical University(CN)First Affiliated Hospital of Wenzhou Medical University(CN)Nanjing Institute of Industry Technology(CN)Anhui Academy of Agricultural Sciences(CN)Stomatology Hospital(CN)Guangxi Center for Disease Prevention and Control(CN)Third Affiliated Hospital of Sun Yat-sen University(CN)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, RNA modifications and cancer, Epigenetics and DNA Methylation, Renal and related cancers
Most-Cited Works
- → Comprehensive molecular characterization of urothelial bladder carcinoma(2014)3,027 cited
- → Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer(2017)2,447 cited
- → Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia(2007)1,802 cited
- → Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia(2009)1,438 cited
- → PD-L1 Expression in Triple-Negative Breast Cancer(2014)1,378 cited
- → Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression(2017)1,338 cited